The European Commission announced on Wednesday 10 March that it had reached an agreement with BioNTech-Pfizer for 4 million additional doses of Covid-19 vaccine. The doses, which will be delivered over the next two weeks, should help to combat coronavirus outbreaks and facilitate free movement across borders, says the institution.
39 million doses already distributed
The increase in dose deliveries in March is the result of the successful expansion of production capacity in Europe, which...